Wird geladen...
Personalising medicine in inflammatory bowel disease—current and future perspectives
Up to 25% of inflammatory bowel disease (IBD) presents during childhood, often with severe and extensive disease, leading to significant morbidity including delayed growth and nutritional impairment. The classical approach to management has centred on differentiation into Crohn’s disease (CD) or ulc...
Gespeichert in:
| Veröffentlicht in: | Transl Pediatr |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
AME Publishing Company
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6382508/ https://ncbi.nlm.nih.gov/pubmed/30881899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tp.2018.12.03 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|